Enhanced cellular accumulation of a P-glycoprotein substrate, rhodamine-123, by caco-2 cells using low molecular weight methoxypolyethylene glycol-block-polycaprolactone diblock copolymers

This publication has 32 references indexed in Scilit:

• Polycaprolactone–b-poly(ethylene oxide) copolymer micelles as a delivery vehicle for dihydrotestosterone
  Journal of Controlled Release, 1999
• Development of copolymers of poly(d,l-lactide) and methoxypolyethylene glycol as micellar carriers of paclitaxel
  Colloids and Surfaces B: Biointerfaces, 1999
• Inhibition of P-Glycoprotein by D-α-Tocopheryl Polyethylene Glycol 1000 Succinate (TPGS)
  Pharmaceutical Research, 1999
• Methoxy poly(ethylene glycol) and ϵ-caprolactone amphiphilic block copolymeric micelle containing indomethacin.
  Journal of Controlled Release, 1998
• Intestinal secretion of drugs. The role of P-glycoprotein and related drug efflux systems in limiting oral drug absorption
  Advanced Drug Delivery Reviews, 1997
• Limited oral bioavailability and active epithelial excretion of paclitaxel (Taxol) caused by P-glycoprotein in the intestine
  Proceedings of the National Academy of Sciences, 1997
• Development of amphiphilic diblock copolymers as micellar carriers of taxol
  International Journal of Pharmaceutics, 1996
• Reversal of multi-drug resistancein vitro by fatty acid PEG fatty acid diesters
  International Journal of Cancer, 1996
• The Use of Surfactants to Enhance the Permeability of Peptides Through Caco-2 Cells by Inhibition of an Apically Polarized Efflux System
  Pharmaceutical Research, 1996
• Reversal of multidrug resistance by surfactants
  British Journal of Cancer, 1992